Pharmaceutical Raw Materials
Parecoxib Sodium is a precursor of vardicxib, which can selectively inhibit cyclooxygenase-2 (COX-2), inhibit the conversion of arachidonic acid to prostaglandin (PG), and inhibit the synthesis of PG, thus exerting analgesic and anti-inflammatory effects, while the inhibition of COX-1 is not obvious, so it does not affect gastrointestinal mucosa, platelet and renal function while exerting analgesic and anti-inflammatory effects.
Molecular Formula: C19H19N2NaO4S
CAS No.: 198470-85-8
Application:
Parecoxib Sodium can selectively inhibit the formation of prostaglandins, but has no effect on thromboxane in platelets. Parecoxib Sodium is generally used for the treatment of acute pain after moderate or severe surgery.
Package:
25kg drum
Certification
We comply with all regulatory requirements in your local market, our suppliers are audited and approved by our QC department in accordance with ISO, GMP, EUGMP, FDA and CEP quality standards.
Specification
EP
Tianjin Chengyi International Trading Co., Ltd.
8th floor 5th Building of North America N1 Cultural and Creative Area,No. 95 South Sports Road, Xiaodian District, Taiyuan, Shanxi, China.
+86 351 828 1248 / +86 351 828 1246
Navigation